JFL Life Sciences Past Earnings Performance
Past criteria checks 3/6
JFL Life Sciences has been growing earnings at an average annual rate of 30%, while the Pharmaceuticals industry saw earnings growing at 17.2% annually. Revenues have been growing at an average rate of 9.6% per year. JFL Life Sciences's return on equity is 9.3%, and it has net margins of 7.1%.
Key information
30.0%
Earnings growth rate
21.2%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | 9.6% |
| Return on equity | 9.3% |
| Net Margin | 7.1% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How JFL Life Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 466 | 33 | 20 | 0 |
| 31 Dec 23 | 454 | 32 | 22 | 0 |
| 30 Sep 23 | 443 | 31 | 24 | 0 |
| 30 Jun 23 | 436 | 30 | 21 | 0 |
| 31 Mar 23 | 428 | 28 | 18 | 0 |
| 31 Dec 22 | 448 | 28 | 16 | 0 |
| 30 Sep 22 | 468 | 27 | 13 | 0 |
| 30 Jun 22 | 402 | 28 | 14 | 0 |
| 31 Mar 22 | 336 | 28 | 14 | 0 |
| 28 Feb 22 | 272 | 28 | 11 | 0 |
| 31 Mar 21 | 328 | 5 | 10 | 0 |
| 31 Mar 20 | 302 | 4 | 13 | 0 |
| 31 Mar 19 | 318 | 3 | 10 | 0 |
Quality Earnings: JFLLIFE has high quality earnings.
Growing Profit Margin: JFLLIFE's current net profit margins (7.1%) are higher than last year (6.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: JFLLIFE's earnings have grown significantly by 30% per year over the past 5 years.
Accelerating Growth: JFLLIFE's earnings growth over the past year (17.8%) is below its 5-year average (30% per year).
Earnings vs Industry: JFLLIFE earnings growth over the past year (17.8%) did not outperform the Pharmaceuticals industry 18.2%.
Return on Equity
High ROE: JFLLIFE's Return on Equity (9.3%) is considered low.